 |
|
Outpatient PID Treatment Works
Brian Vastag
JAMA. 2002;287:3070.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Outpatient treatment of pelvic inflammatory disease (PID), a leading cause of infertility in women, is just as effective as inpatient treatment, concludes a long-term study funded by the Agency for Healthcare Research and Quality (AHRQ). The findings may obviate standard 48-hour hospital stays for 85 000 women annually.
The PID Evaluation and Clinical Health (PEACH) study followed up 823 women for 35 months. Half the patients received treatment in a hospital that included several intravenous doses of cefoxitin plus doxycycline. The other, outpatient, half received a single intramuscular injection of cefoxitin and an oral dose of probenecid, followed by 2 weeks of oral doxycycline.
University of Pittsburgh investigator Roberta Ness, MD, MPH, reported that short-term pain and microbial outcomes were similar in both groups. Long-term pregnancy outcomes were also similar. After 35 months, about 42% in each group had achieved a nonectopic pregnancy; time to pregnancy was also nearly . . . [Full Text of this Article]
|
